199 related articles for article (PubMed ID: 21145533)
1. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis.
Kalinina Ayuso V; van de Winkel EL; Rothova A; de Boer JH
Am J Ophthalmol; 2011 Feb; 151(2):217-22. PubMed ID: 21145533
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.
Goebel JC; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
Br J Ophthalmol; 2011 Feb; 95(2):209-13. PubMed ID: 20584711
[TBL] [Abstract][Full Text] [Related]
4. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis.
Tappeiner C; Heinz C; Roesel M; Heiligenhaus A
Acta Ophthalmol; 2011 Sep; 89(6):e521-7. PubMed ID: 21586097
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
[TBL] [Abstract][Full Text] [Related]
6. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Kump LI; Castañeda RA; Androudi SN; Reed GF; Foster CS
Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
[TBL] [Abstract][Full Text] [Related]
7. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
Thorne JE; Woreta F; Kedhar SR; Dunn JP; Jabs DA
Am J Ophthalmol; 2007 May; 143(5):840-846. PubMed ID: 17362866
[TBL] [Abstract][Full Text] [Related]
8. Etanercept and uveitis in patients with juvenile idiopathic arthritis.
Schmeling H; Horneff G
Rheumatology (Oxford); 2005 Aug; 44(8):1008-11. PubMed ID: 15855187
[TBL] [Abstract][Full Text] [Related]
9. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
Tappeiner C; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
Eye (Lond); 2009 May; 23(5):1192-8. PubMed ID: 18551142
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).
Heiligenhaus A; Miserocchi E; Heinz C; Gerloni V; Kotaniemi K
Rheumatology (Oxford); 2011 Aug; 50(8):1390-4. PubMed ID: 21378109
[TBL] [Abstract][Full Text] [Related]
11. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
Chan AY; Liu DT
J Rheumatol; 2006 Jan; 33(1):198; author reply 198. PubMed ID: 16395772
[No Abstract] [Full Text] [Related]
13. Uveitis related to juvenile idiopathic arthritis: familial cases and possible genetic implication in the pathogenesis.
Julián K; Terrada C; Quartier P; Lehoang P; Bodaghi B
Ocul Immunol Inflamm; 2010 Jun; 18(3):172-7. PubMed ID: 20482390
[TBL] [Abstract][Full Text] [Related]
14. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.
Sijssens KM; Rothova A; Van De Vijver DA; Stilma JS; De Boer JH
Am J Ophthalmol; 2007 Oct; 144(4):574-9. PubMed ID: 17706583
[TBL] [Abstract][Full Text] [Related]
17. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis.
Kalinina Ayuso V; Ten Cate HA; van der Does P; Rothova A; de Boer JH
Am J Ophthalmol; 2010 Jun; 149(6):994-999.e5. PubMed ID: 20510688
[TBL] [Abstract][Full Text] [Related]
18. Etanercept therapy in children with treatment-resistant uveitis.
Reiff A; Takei S; Sadeghi S; Stout A; Shaham B; Bernstein B; Gallagher K; Stout T
Arthritis Rheum; 2001 Jun; 44(6):1411-5. PubMed ID: 11407702
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
20. The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty.
Hoeve M; Kalinina Ayuso V; Schalij-Delfos NE; Los LI; Rothova A; de Boer JH
Br J Ophthalmol; 2012 Jun; 96(6):852-6. PubMed ID: 22399692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
